Weder, B., Mozaffari, M., Biedermann, L., Mamie, C., Moncsek, A., Wang, L., . . . Hausmann, M. (2018). BCL‐2 levels do not predict azathioprine treatment response in inflammatory bowel disease, but inhibition induces lymphocyte apoptosis and ameliorates colitis in mice. Clin Exp Immunol.
Chicago Style CitationWeder, B., et al. "BCL‐2 Levels Do Not Predict Azathioprine Treatment Response in Inflammatory Bowel Disease, but Inhibition Induces Lymphocyte Apoptosis and Ameliorates Colitis in Mice." Clin Exp Immunol 2018.
Cita MLAWeder, B., et al. "BCL‐2 Levels Do Not Predict Azathioprine Treatment Response in Inflammatory Bowel Disease, but Inhibition Induces Lymphocyte Apoptosis and Ameliorates Colitis in Mice." Clin Exp Immunol 2018.
Atenció: Aquestes cites poden no estar 100% correctes.